CB1-IN-3

• Description:

  CB1-IN-3 (Compound 6i) is a potent cannabinoid type 1 receptor (CB1) inhibitor. CB1-IN-3 is promising for research of obesity, inflammation, and neurological diseases[1].

• UNSPSC:

  12352005

• Target:

  Cannabinoid Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Metabolic Disease; Inflammation/Immunology; Neurological Disease

• Smiles:

  O=C(NC1=CC=CC(C(CN2C=CC=N2)=O)=C1)NC3=CC=C(C)C([N+]([O-])=O)=C3

• Molecular Formula:

  C19H17N5O4

• Molecular Weight:

  379.37

• References & Citations:

  [1]Tsemperlidou E, et al. Synthesis of New N, N'-Diarylureas and Their Theoretical Study as Cannabinoid-1 Receptor Inhibitors. Chempluschem. 2025 Jun 13:e2500270.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CB1